U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.337G>T (p.Glu113Ter) AND Familial hypercholesterolemia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002229195.6

Allele description [Variation Report for NM_000527.5(LDLR):c.337G>T (p.Glu113Ter)]

NM_000527.5(LDLR):c.337G>T (p.Glu113Ter)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.337G>T (p.Glu113Ter)
Other names:
FH Paris-5; NP_000518.1:p.E113*
HGVS:
  • NC_000019.10:g.11105243G>T
  • NG_009060.1:g.20863G>T
  • NM_000527.5:c.337G>TMANE SELECT
  • NM_001195798.2:c.337G>T
  • NM_001195799.2:c.214G>T
  • NM_001195800.2:c.314-2149G>T
  • NM_001195803.2:c.314-1322G>T
  • NP_000518.1:p.Glu113Ter
  • NP_000518.1:p.Glu113Ter
  • NP_001182727.1:p.Glu113Ter
  • NP_001182728.1:p.Glu72Ter
  • LRG_274t1:c.337G>T
  • LRG_274:g.20863G>T
  • LRG_274p1:p.Glu113Ter
  • NC_000019.9:g.11215919G>T
  • NM_000527.4:c.337G>T
  • c.337G>T
  • p.(Glu113*)
  • p.Glu113*
Protein change:
E113*
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001705;
Molecular consequence:
  • NM_001195800.2:c.314-2149G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195803.2:c.314-1322G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000527.5:c.337G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001195798.2:c.337G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001195799.2:c.214G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000833264Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 13, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network., Boileau C, Varret M, Rabès JP.

Hum Mutat. 2010 Nov;31(11):E1811-24. doi: 10.1002/humu.21348.

PubMed [citation]
PMID:
20809525
PMCID:
PMC3152176

Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.

Jiang L, Benito-Vicente A, Tang L, Etxebarria A, Cui W, Uribe KB, Pan XD, Ostolaza H, Yang SW, Zhou YJ, Martin C, Wang LY.

Atherosclerosis. 2017 Aug;263:163-170. doi: 10.1016/j.atherosclerosis.2017.06.014. Epub 2017 Jun 8.

PubMed [citation]
PMID:
28645073
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000833264.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change creates a premature translational stop signal (p.Glu113*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with familial hypercholesterolemia (PMID: 10532689, 11196104, 11462246, 11933210). This variant is also known as Stop 92, E92X. ClinVar contains an entry for this variant (Variation ID: 226320). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024